CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth

Published on Dec 7, 2020in JCI insight6.205
· DOI :10.1172/JCI.INSIGHT.138808
Xiaodong Zhuang6
Estimated H-index: 6
(University of Birmingham),
Xiaodong Zhuang10
Estimated H-index: 10
(University of Birmingham)
+ 14 AuthorsSteven P. Lee29
Estimated H-index: 29
(University of Birmingham)
Engineering T cells to express chimeric antigen receptors (CARs) specific for antigens on hematological cancers has yielded remarkable clinical responses, but with solid tumors, benefit has been more limited. This may reflect lack of suitable target antigens, immune evasion mechanisms in malignant cells, and/or lack of T cell infiltration into tumors. An alternative approach, to circumvent these problems, is targeting the tumor vasculature rather than the malignant cells directly. CLEC14A is a glycoprotein selectively overexpressed on the vasculature of many solid human cancers and is, therefore, of considerable interest as a target antigen. Here, we generated CARs from 2 CLEC14A-specific antibodies and expressed them in T cells. In vitro studies demonstrated that, when exposed to their target antigen, these engineered T cells proliferate, release IFN-γ, and mediate cytotoxicity. Infusing CAR engineered T cells into healthy mice showed no signs of toxicity, yet these T cells targeted tumor tissue and significantly inhibited tumor growth in 3 mouse models of cancer (Rip-Tag2, mPDAC, and Lewis lung carcinoma). Reduced tumor burden also correlated with significant loss of CLEC14A expression and reduced vascular density within malignant tissues. These data suggest the tumor vasculature can be safely and effectively targeted with CLEC14A-specific CAR T cells, offering a potent and widely applicable therapy for cancer.
📖 Papers frequently viewed together
3 Citations
60 Citations
84 Citations
#1Joseph Robinson (University of Birmingham)H-Index: 5
#2Katharine Whitworth (University of Birmingham)H-Index: 3
Last. Steven P. Lee (University of Birmingham)H-Index: 29
view all 6 authors...
Earlier studies identified the transmembrane cell surface C-type lectin CLEC14A as a putative tumour endothelial marker. For CLEC14A to progress as a vascular target in solid tumours an in-depth analysis of CLEC14A expression in human healthy and tumour tissue is needed. It is here shown that an analysis of 5332 RNA expression profiles in the public domain confirmed high expression of CLEC14A in tumour compared to healthy human tissue. It is further shown by immunohistochemistry that CLEC14A pro...
3 CitationsSource
#1Kristina Petrovic (University of Birmingham)H-Index: 1
#2Joseph Robinson (University of Birmingham)H-Index: 5
Last. Steven P. Lee (University of Birmingham)H-Index: 29
view all 6 authors...
Engineering T-cells to express receptors specific for antigens present on tumour tissue is proving a highly effective treatment for some leukaemias. However, extending this to solid tumours requires antigens that can be safely and effectively targeted. TEM8, a marker overexpressed on the vasculature of some solid tumours, has been proposed as one such target. A recent report stated that T-cells engineered to express a TEM8-specific chimeric antigen receptor (CAR), when injected into mouse models...
10 CitationsSource
#1Yushu Joy Xie (MIT: Massachusetts Institute of Technology)H-Index: 2
#2Michael Dougan (Harvard University)H-Index: 28
Last. Hidde L. Ploegh (Boston Children's Hospital)H-Index: 151
view all 11 authors...
Chimeric antigen receptor (CAR) T cell therapy has been successful in clinical trials against hematological cancers, but has experienced challenges in the treatment of solid tumors. One of the main difficulties lies in a paucity of tumor-specific targets that can serve as CAR recognition domains. We therefore focused on developing VHH-based, single-domain antibody (nanobody) CAR T cells that target aspects of the tumor microenvironment conserved across multiple cancer types. Many solid tumors ev...
88 CitationsSource
#1Matteo Bocci (Lund University)H-Index: 7
#2Jonas SjölundH-Index: 14
Last. Kristian PietrasH-Index: 46
view all 8 authors...
Cancer cells sustain their metabolic needs through nutrients and oxygen supplied by the bloodstream. The requirement for tumor angiogenesis has been therapeutically exploited in the clinical setting mainly by means of inhibition of the vascular endothelial growth factor family of ligands and receptors. Despite promising results in preclinical models, the benefits for patients proved to be limited. Inadequate efficacy similarly halted the development of agents impinging on the activity of the act...
30 CitationsSource
#1Tiara T. Byrd (BCM: Baylor College of Medicine)H-Index: 10
#2Kristen Fousek (BCM: Baylor College of Medicine)H-Index: 12
Last. Nabil Ahmed (Center for Cell and Gene Therapy)H-Index: 26
view all 25 authors...
Triple-negative breast cancer (TNBC) is an aggressive disease lacking targeted therapy. In this study, we developed a CAR T cell-based immunotherapeutic strategy to target TEM8, a marker initially defined on endothelial cells in colon tumors that was discovered recently to be upregulated in TNBC. CAR T cells were developed that upon specific recognition of TEM8 secreted immunostimulatory cytokines and killed tumor endothelial cells as well as TEM8-positive TNBC cells. Notably, the TEM8 CAR T cel...
57 CitationsSource
#1Elise A. Chong (UPenn: University of Pennsylvania)H-Index: 15
#2J. Joseph Melenhorst (UPenn: University of Pennsylvania)H-Index: 56
Last. Stephen J. Schuster (UPenn: University of Pennsylvania)H-Index: 63
view all 8 authors...
To the editor: Antibodies blocking the programmed death 1 receptor (PD-1) on T cells produce tumor regression in multiple cancers by disrupting the PD-L1/PD-1 (programmed death-ligand 1/programmed cell death protein 1) immune inhibitory axis.[1][1][⇓][2][⇓][3][⇓][4]-[5][5] This approach to
246 CitationsSource
#1Lee Sk (Yonsei University)H-Index: 7
#1S.-W. Lee (Yonsei University)H-Index: 7
Last. Young Guen KwonH-Index: 68
view all 10 authors...
: Controlled angiogenesis and lymphangiogenesis are essential for tissue development, function, and repair. However, aberrant neovascularization is an essential pathogenic mechanism in many human diseases, including diseases involving tumor growth and survival. Here, we have demonstrated that mice deficient in C-type lectin family 14 member A (CLEC14A) display enhanced angiogenic sprouting and hemorrhage as well as enlarged jugular lymph sacs and lymphatic vessels. CLEC14A formed a complex with ...
21 CitationsSource
#1Maud-Emmanuelle Gilles (University of Paris-Est)H-Index: 8
#2Federica Maione (UNITO: University of Turin)H-Index: 19
Last. Ilaria Cascone (University of Paris-Est)H-Index: 16
view all 18 authors...
Pancreatic cancer is a highly aggressive tumor, mostly resistant to the standard treatments. Nucleolin is overexpressed in cancers and its inhibition impairs tumor growth. Herein, we showed that nucleolin was overexpressed in human specimens of pancreatic ductal adenocarcinoma (PDAC) and that the overall survival significantly increased in patients with low levels of nucleolin. The nucleolin antagonist N6L strongly impaired the growth of primary tumors and liver metastasis in an orthotopic mouse...
60 CitationsSource
#1Omkar U. Kawalekar (UPenn: University of Pennsylvania)H-Index: 13
#2Roddy S. O’Connor (UPenn: University of Pennsylvania)H-Index: 20
Last. Carl H. June (UPenn: University of Pennsylvania)H-Index: 169
view all 14 authors...
Summary Chimeric antigen receptors (CARs) redirect T cell cytotoxicity against cancer cells, providing a promising approach to cancer immunotherapy. Despite extensive clinical use, the attributes of CAR co-stimulatory domains that impact persistence and resistance to exhaustion of CAR-T cells remain largely undefined. Here, we report the influence of signaling domains of coreceptors CD28 and 4-1BB on the metabolic characteristics of human CAR T cells. Inclusion of 4-1BB in the CAR architecture p...
459 CitationsSource
#1Peter J. Noy (University of Birmingham)H-Index: 15
#2P Lodhia (University of Birmingham)H-Index: 3
Last. Roy Bicknell (University of Birmingham)H-Index: 84
view all 8 authors...
We previously identified CLEC14A as a tumour endothelial marker. Here we show that CLEC14A is a regulator of sprouting angiogenesis in vitro and in vivo. Using a human umbilical vein endothelial cell spheroid-sprouting assay, we found CLEC14A to be a regulator of sprout initiation. Analysis of endothelial sprouting in aortic ring and in vivo subcutaneous sponge assays from clec14a+/+ and clec14a−/− mice revealed defects in sprouting angiogenesis in CLEC14A-deficient animals. Tumour growth was re...
39 CitationsSource
Cited By24
#1Emily Feng (McMaster University)H-Index: 1
#2Elizabeth Balint (McMaster University)H-Index: 1
Last. Ali A. Ashkar (McMaster University)H-Index: 54
view all 0 authors...
Herpes simplex virus type 2 (HSV-2) infection is one of the most prevalent sexually transmitted infections that disproportionately impacts women worldwide. Currently, there are no vaccines or curative treatments, resulting in life-long infection. The mucosal environment of the female reproductive tract (FRT) is home to a complex array of local immune defenses that must be carefully coordinated to protect against genital HSV-2 infection, while preventing excessive inflammation to prevent disease ...
#2Sudhanshu VratiH-Index: 34
Last. Arup Banerjee (ARUP Laboratories)
view all 3 authors...
Neutrophils are versatile immune effector cells essential for mounting a first-line defense against invading pathogens. However, uncontrolled activation can lead to severe life-threatening complications. Neutrophils exist as a heterogeneous population, and their interaction with pathogens and other immune cells may shape the outcome of the host immune response. Diverse classes of viruses, including the recently identified novel SARS-CoV-2, have shown to alter the various aspects of neutrophil bi...
#1Christopher A Beaudoin (University of Cambridge)H-Index: 3
#2Arian R. Jamasb (University of Cambridge)H-Index: 6
Last. Pedro H M Torres (UFRJ: Federal University of Rio de Janeiro)H-Index: 8
view all 11 authors...
Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot...
#1Dorina BelottiH-Index: 22
#2Denise PinessiH-Index: 6
Last. Giulia TarabolettiH-Index: 55
view all 3 authors...
Blood vessels in tumors are formed through a variety of different mechanisms, each generating vessels with peculiar structural, molecular, and functional properties. This heterogeneity has a major impact on tumor response or resistance to antineoplastic therapies and is now emerging as a promising target for strategies to prevent drug resistance and improve the distribution and efficacy of antineoplastic treatments. This review presents evidence of how different mechanisms of tumor vessel format...
#1Pooria Safarzadeh Kozani (TMU: Tarbiat Modares University)H-Index: 4
#2Pouya Safarzadeh Kozani (University of Gilan)H-Index: 4
Last. Fatemeh Rahbarizadeh (TMU: Tarbiat Modares University)H-Index: 22
view all 3 authors...
Chimeric antigen receptor T cell (CAR-T) therapy has so far proved itself as a reliable therapeutic option for the treatment of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), and mantle cell lymphoma (MCL). However, this picture is not as colorful when it comes to the treatment of solid tumors mainly due to the lack of definitive tumor antigens, as well as the immunosuppressive tumor microenvironments and poor ...
6 CitationsSource
#1Nilesh M Agalave (UTD: University of Texas at Dallas)H-Index: 7
#2Prapti H. Mody (UTD: University of Texas at Dallas)H-Index: 2
Last. Michael D. Burton (UTD: University of Texas at Dallas)H-Index: 17
view all 5 authors...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect that occurs in up to 63% of patients and has no known effective treatment. A majority of studies do not effectively assess sex differences in the onset and persistence of CIPN. Here we investigated the onset of CIPN, a point of therapeutic intervention where we may limit, or even prevent the development of CIPN. We hypothesized that cap-dependent translation mechanisms are important in early CIPN development a...
1 CitationsSource
Last. Nanda Rk
view all 12 authors...
#1Rajiv G. Menon (NYU: New York University)H-Index: 5
#2Ding Xia (NYU: New York University)H-Index: 17
Last. Ravinder R. Regatte (NYU: New York University)H-Index: 41
view all 4 authors...
Impaired oxidative metabolism is one of multi-variate factors leading to exercise intolerance in heart failure patients. The purpose of the study was to demonstrate the use of dynamic 31P magnetic resonance spectroscopy (MRS) and 31P magnetic resonance imaging (MRI) techniques to measure PCr resynthesis rate post-exercise as a biomarker for oxidative metabolism in skeletal muscle in HF patients and controls. In this prospective imaging study, we recruited six HF patients and five healthy control...
#1Guangna Liu (THU: Tsinghua University)H-Index: 3
#2Wei Rui (THU: Tsinghua University)H-Index: 2
Last. Xin Lin (THU: Tsinghua University)H-Index: 41
view all 4 authors...
Chimeric antigen receptor (CAR)-T cell therapy has achieved successful outcomes against hematological malignancies and provided a new impetus for treating solid tumors. However, the efficacy of CAR-T cells for solid tumors remains unsatisfactory. The tumor microenvironment has an important role in interfering with and inhibiting the effector function of immune cells, among which upregulated inhibitory checkpoint receptors, soluble suppressive cytokines, altered chemokine expression profiles, abe...
2 CitationsSource